APA

Reyes-Loyola P., Rodríguez-Henríquez P., Ballinas-Verdugo M. A., Amezcua-Castillo L. M., Juárez-Vicuña Y., Jiménez-Rojas V., Márquez-Velasco R., Sánchez-Muñoz F. & Amezcua-Guerra L. M. (20191203). Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy. : Clinical rheumatology.

Chicago

Reyes-Loyola Paola, Rodríguez-Henríquez Pedro, Ballinas-Verdugo Martha A, Amezcua-Castillo Luis M, Juárez-Vicuña Yaneli, Jiménez-Rojas Valentín, Márquez-Velasco Ricardo, Sánchez-Muñoz Fausto and Amezcua-Guerra Luis M. 20191203. Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy. : Clinical rheumatology.

Harvard

Reyes-Loyola P., Rodríguez-Henríquez P., Ballinas-Verdugo M. A., Amezcua-Castillo L. M., Juárez-Vicuña Y., Jiménez-Rojas V., Márquez-Velasco R., Sánchez-Muñoz F. and Amezcua-Guerra L. M. (20191203). Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy. : Clinical rheumatology.

MLA

Reyes-Loyola Paola, Rodríguez-Henríquez Pedro, Ballinas-Verdugo Martha A, Amezcua-Castillo Luis M, Juárez-Vicuña Yaneli, Jiménez-Rojas Valentín, Márquez-Velasco Ricardo, Sánchez-Muñoz Fausto and Amezcua-Guerra Luis M. Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naïve to anti-TNF therapy. : Clinical rheumatology. 20191203.